Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B

|
News,Business,Pharmaceutical Industry

NEW YORK (AP) — Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B.

View article comments Leave a comment